As of 2025-07-09, the Intrinsic Value of Advanced Medical Solutions Group PLC (AMS.L) is 106.40 GBP. This AMS.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 206.00 GBP, the upside of Advanced Medical Solutions Group PLC is -48.40%.
The range of the Intrinsic Value is 63.22 - 223.26 GBP
Based on its market price of 206.00 GBP and our intrinsic valuation, Advanced Medical Solutions Group PLC (AMS.L) is overvalued by 48.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 63.22 - 223.26 | 106.40 | -48.4% |
| DCF (Growth 10y) | 108.68 - 342.14 | 172.08 | -16.5% |
| DCF (EBITDA 5y) | 139.92 - 229.15 | 188.79 | -8.4% |
| DCF (EBITDA 10y) | 183.53 - 333.10 | 257.38 | 24.9% |
| Fair Value | 15.94 - 15.94 | 15.94 | -92.26% |
| P/E | 62.68 - 203.37 | 132.57 | -35.6% |
| EV/EBITDA | 102.21 - 214.31 | 168.76 | -18.1% |
| EPV | 42.83 - 78.96 | 60.90 | -70.4% |
| DDM - Stable | 23.90 - 74.30 | 49.10 | -76.2% |
| DDM - Multi | 100.67 - 233.02 | 139.54 | -32.3% |
| Market Cap (mil) | 458.33 |
| Beta | 1.97 |
| Outstanding shares (mil) | 2.22 |
| Enterprise Value (mil) | 527.86 |
| Market risk premium | 5.98% |
| Cost of Equity | 10.10% |
| Cost of Debt | 11.06% |
| WACC | 9.86% |